Cargando…

Gain‐of‐function p53 activates multiple signaling pathways to induce oncogenicity in lung cancer cells

Gain‐of‐function (GOF) mutants of p53 upregulate genes implicated in cell proliferation and oncogenesis. Here, we report that GOF p53 induces tumorigenicity through simultaneous activation of key oncogenic pathways including those controlling putative tumor‐initiating cell functions. We determined t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vaughan, Catherine A., Singh, Shilpa, Grossman, Steven R., Windle, Brad, Deb, Swati Palit, Deb, Sumitra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467493/ https://www.ncbi.nlm.nih.gov/pubmed/28423230 http://dx.doi.org/10.1002/1878-0261.12068

Ejemplares similares

The oncogenicity of tumor-derived mutant p53 is enhanced by the recruitment of PLK3
por: Vaughan, Catherine A., et al.
Publicado: (2021)

Preferred binding of gain-of-function mutant p53 to bidirectional promoters with coordinated binding of ETS1 and GABPA to multiple binding sites
por: Vaughan, Catherine A., et al.
Publicado: (2014)

Addiction of lung cancer cells to GOF p53 is promoted by up-regulation of epidermal growth factor receptor through multiple contacts with p53 transactivation domain and promoter
por: Vaughan, Catherine A., et al.
Publicado: (2016)

The human oncoprotein MDM2 induces replication stress eliciting early intra-S-phase checkpoint response and inhibition of DNA replication origin firing
por: Frum, Rebecca A., et al.
Publicado: (2014)

Targeting Oncogenic Mutant p53 and BCL-2 for Small Cell Lung Cancer Treatment
por: Neely, Victoria, et al.
Publicado: (2023)

Regulators of Oncogenic Mutant TP53 Gain of Function
por: Yamamoto, Satomi, et al.
Publicado: (2018)

Oncogenic Gain of Function in Glioblastoma Is Linked to Mutant p53 Amyloid Oligomers
por: Pedrote, Murilo M., et al.
Publicado: (2020)

Comparison of Effects of p53 Null and Gain-of-Function Mutations on Salivary Tumors in MMTV-Hras Transgenic Mice
por: Jiang, Dadi, et al.
Publicado: (2015)

Control of Nucleotide Metabolism Enables Mutant p53’s Oncogenic Gain-of-Function Activity
por: Schmidt, Valentina, et al.
Publicado: (2017)

TP53-Status-Dependent Oncogenic EZH2 Activity in Pancreatic Cancer
por: Versemann, Lennart, et al.
Publicado: (2022)

TC2N, a novel oncogene, accelerates tumor progression by suppressing p53 signaling pathway in lung cancer
por: Hao, Xiang-lin, et al.
Publicado: (2018)

TP53: an oncogene in disguise
por: Soussi, T, et al.
Publicado: (2015)

FOXM1 allows human keratinocytes to bypass the oncogene-induced differentiation checkpoint in response to gain of MYC or loss of p53
por: Molinuevo, R, et al.
Publicado: (2017)

Multiple mechanisms can disrupt oncogenic pathways in multiple myeloma
por: Hoang, Phuc H., et al.
Publicado: (2018)

IL1RAP potentiates multiple oncogenic signaling pathways in AML
por: Mitchell, Kelly, et al.
Publicado: (2018)

Gain-of-function mutant p53 together with ERG proto-oncogene drive prostate cancer by beta-catenin activation and pyrimidine synthesis
por: Ding, Donglin, et al.
Publicado: (2023)

The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence
por: Haferkamp, Sebastian, et al.
Publicado: (2009)

How TP53 (almost) became an oncogene
por: Weinberg, Robert A
Publicado: (2019)

Do Mutations Turn p53 into an Oncogene?
por: Pitolli, Consuelo, et al.
Publicado: (2019)

Harnessing the vulnerabilities of p53 mutants in lung cancer – Focusing on the proteasome: a new trick for an old foe?
por: Oduah, Eziafa I., et al.
Publicado: (2020)

Regional gain and global loss of 5-hydroxymethylcytosine coexist in genitourinary cancers and regulate different oncogenic pathways
por: Qi, Jie, et al.
Publicado: (2022)

Context is everything: extrinsic signalling and gain-of-function p53 mutants
por: Amelio, Ivano, et al.
Publicado: (2020)

Oncogenic signaling pathway dysregulation landscape reveals the role of pathways at multiple omics levels in pan-cancer
por: Wang, Na, et al.
Publicado: (2022)

T-Cell Leukemia/Lymphoma 1 (TCL1): An Oncogene Regulating Multiple Signaling Pathways
por: Paduano, Francesco, et al.
Publicado: (2018)

REGγ is associated with multiple oncogenic pathways in human cancers
por: He, Jing, et al.
Publicado: (2012)

Characterization of the p53 Response to Oncogene-Induced Senescence
por: Ruiz, Lidia, et al.
Publicado: (2008)

Expression of the p53 oncogene in acute myeloblastic leukemia
Publicado: (1986)

Oncogene-mediated regulation of p53 ISGylation and functions
por: Huang, Yi-Fu, et al.
Publicado: (2014)

Targeting Oncogenic Mutant p53 for Cancer Therapy
por: Parrales, Alejandro, et al.
Publicado: (2015)

p53 Deficiency-Dependent Oncogenicity of Runx3
por: Ito, Kosei, et al.
Publicado: (2023)

Oncogenic switching of hypoxia signalling pathways
por: Ratcliffe, Peter J
Publicado: (2014)

Curcumin Differs from Tetrahydrocurcumin for Molecular Targets, Signaling Pathways and Cellular Responses
por: Aggarwal, Bharat B., et al.
Publicado: (2014)

Pharmacological Modulation of Ubiquitin-Proteasome Pathways in Oncogenic Signaling
por: Sharma, Anmol, et al.
Publicado: (2021)

Effect of maternal Tp53 gene G412C polymorphism on neural tube defects: A study from North India
por: Arora, Jyoti, et al.
Publicado: (2012)

CtBP- an emerging oncogene and novel small molecule drug target: Advances in the understanding of its oncogenic action and identification of therapeutic inhibitors
por: Dcona, M. Michael, et al.
Publicado: (2017)

Substance use in women: Current status and future directions
por: Lal, Rakesh, et al.
Publicado: (2015)

DRAM2 acts as an oncogene in non-small cell lung cancer and suppresses the expression of p53
por: Wudu, Muli, et al.
Publicado: (2019)

Regulatory Cross-Talks and Cascades in Rice Hormone Biosynthesis Pathways Contribute to Stress Signaling
por: Deb, Arindam, et al.
Publicado: (2016)

Multiplicity Dependence of Charmonia Suppression in pp Collisions at the LHC Energies
por: Singh, Captain R, et al.
Publicado: (2022)

Gain-of-function mutant p53: history and speculation
por: Bargonetti, Jill, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ui4ikibeiu7chtbdejt2of1q9u